Course of platelet miRNAs after cessation of P2Y12 antagonists.

Bernhard JägerStefan StojkovicPaul M HallerEdith PiackovaBeatrice S KahlTijana AndricKris G VargasJohann WojtaKurt Huber

Published in: European journal of clinical investigation (2019)

In patients with CAD, ticagrelor intake is associated with increased levels of platelet miRNAs as compared to clopidogrel and prasugrel. Platelet miRNAs are not useful to monitor platelet function after cessation of P2Y12 inhibitors.

Keyphrases

percutaneous coronary intervention
acute coronary syndrome
coronary artery disease
antiplatelet therapy
body mass index
atrial fibrillation